Greg Tourangeau - Principal Accounting Officer at Fulcrum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Principal Accounting Officer
Stock Symbol
FULC on Nasdaq
All Insider Reports
All Insider Reports

Greg Tourangeau - trading volume in the past year for Fulcrum Therapeutics, Inc.

Holdings reported by Greg Tourangeau for Fulcrum Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 11.6K $89.8K $7.76 May 7, 2024 Direct
Stock Option (right to buy) 76.1K Jan 24, 2025 Direct Common Stock

Transactions reported by Greg Tourangeau for Fulcrum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.